Attention Deficit Hyperactivity Disorder is one of the most common neurodevelopmental disorders of childhood, often lasting into adulthood. Though it is commonly treated with a “stimulant” medication, there have been concerns that such drugs could stunt a child’s growth. Now, a new study suggests this type of medication does not affect children’s final height in adulthood.

Share on Pinterest The latest study reveals that stimulant medication taken by children treated for ADHD does not affect their final height in adulthood.

The longitudinal study is published in the American Academy of Pediatrics’ (AAP) journal Pediatrics.

According to the American Psychiatric Association, 5% of children have Attention Deficit Hyperactivity Disorder (ADHD). But studies in the US indicate that this rate is higher. Recent surveys of parents have found that around 11% of children aged 4-17 have been diagnosed with ADHD as of 2011, totaling 6.4 million.

Children with the disorder usually have difficulty paying attention, controlling impulsive behavior or are overly active. Though the underlying causes and risk factors for ADHD are not known, the Centers for Disease Control and Prevention (CDC) note that genetics may play a role.

Additionally, researchers are currently investigating other potential causes and risk factors, including brain injury, environmental exposures, alcohol and tobacco use in pregnancy, premature delivery and low birth rate.

Though it may seem counterproductive to give an overactive child a stimulant, the most commonly used medication for treating ADHD is a type of stimulant medication, which has a calming effect on children with the condition.

According to the CDC, between 70-80% of children with ADHD respond positively to such medications.